Demyelinating and neurologic events reported in association with tumor necrosis factor ? antagonism: By what mechanisms could tumor necrosis factor ? antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?
Top Cited Papers
- 1 September 2001
- journal article
- review article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 44 (9) , 1977-1983
- https://doi.org/10.1002/1529-0131(200109)44:9<1977::aid-art345>3.0.co;2-6
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Multiple SclerosisNew England Journal of Medicine, 2000
- Rheumatoid arthritis and its animal models: the role of TNF-α and the possible absence of specific immune reactionsCurrent Opinion in Immunology, 1999
- Tumour necrosis factor and other cytokines in murine lupusAnnals of the Rheumatic Diseases, 1999
- TNF neutralization in MSNeurology, 1999
- Tumor necrosis factor‐a and the progression of diabetes in non‐obese diabetic miceImmunological Reviews, 1999
- Epidemiology and Estimated Population Burden of Selected Autoimmune Diseases in the United StatesClinical Immunology and Immunopathology, 1997
- Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion ProteinNew England Journal of Medicine, 1997
- The role of TNFα and related cytokines in the development and function of the autoreactive T-cell repertoireResearch in Immunology, 1997
- Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2Neurology, 1996
- Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritisThe Lancet, 1994